Nello Mainolfi
Chief Executive Officer at Kymera Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Kymera Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Kymera Therapeutics Inc. June 24, 202694.9%
-
Kymera Therapeutics Inc. June 15, 202395.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 1, 2026 | Kymera Therapeutics Inc. | Option exercise | +30,000 | $2.08 | $62,400 |
| Oct 1, 2026 | Kymera Therapeutics Inc. | Open-market sale | −3,525 | $111.44 | $392,826 |
| Oct 1, 2026 | Kymera Therapeutics Inc. | Open-market sale | −5,506 | $112.42 | $618,985 |
| Oct 1, 2026 | Kymera Therapeutics Inc. | Open-market sale | −4,876 | $113.24 | $552,158 |
| Oct 1, 2026 | Kymera Therapeutics Inc. | Open-market sale | −7,601 | $114.43 | $869,782 |
| Oct 1, 2026 | Kymera Therapeutics Inc. | Open-market sale | −8,230 | $115.40 | $949,742 |
| Oct 1, 2026 | Kymera Therapeutics Inc. | Open-market sale | −262 | $116.12 | $30,423 |
| Jul 7, 2026 | Kymera Therapeutics Inc. | Option exercise | +50,000 | $2.08 | $104,000 |
| Jul 7, 2026 | Kymera Therapeutics Inc. | Open-market sale | −50,000 | $119.00 | $5,950,000 |
| Jul 1, 2026 | Kymera Therapeutics Inc. | Option exercise | +80,000 | $2.08 | $166,400 |
| Jul 1, 2026 | Kymera Therapeutics Inc. | Open-market sale | −1,883 | $112.80 | $212,402 |
| Jul 1, 2026 | Kymera Therapeutics Inc. | Open-market sale | −6,626 | $113.98 | $755,231 |
| Jul 1, 2026 | Kymera Therapeutics Inc. | Open-market sale | −24,105 | $114.96 | $2,771,111 |
| Jul 1, 2026 | Kymera Therapeutics Inc. | Open-market sale | −44,050 | $115.69 | $5,096,145 |
| Jul 1, 2026 | Kymera Therapeutics Inc. | Open-market sale | −3,336 | $116.56 | $388,844 |
Questions about Nello Mainolfi
What boards is Nello Mainolfi on?
Nello Mainolfi sits on the board of Kymera Therapeutics Inc.
What company is Nello Mainolfi the CEO of?
Nello Mainolfi is Chief Executive Officer of Kymera Therapeutics Inc.
How long has Nello Mainolfi served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.